These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7746174)

  • 41. Efficacy of maternal and neonatal chemoprophylaxis for early-onset group B streptococcal disease.
    Stafford IA; Stewart RD; Sheffield JS; Wendel GD; Sanchez PJ; McIntire DD; Roberts SW
    Obstet Gynecol; 2012 Jul; 120(1):123-9. PubMed ID: 22914400
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk factors for early onset neonatal group B streptococcal sepsis: case-control study.
    Oddie S; Embleton ND
    BMJ; 2002 Aug; 325(7359):308. PubMed ID: 12169506
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevention of group B streptococcal infection.
    Noya FJ; Baker CJ
    Infect Dis Clin North Am; 1992 Mar; 6(1):41-55. PubMed ID: 1578122
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antimicrobial prevention of early-onset group B streptococcal sepsis: estimates of risk reduction based on a critical literature review.
    Benitz WE; Gould JB; Druzin ML
    Pediatrics; 1999 Jun; 103(6):e78. PubMed ID: 10353975
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intrapartum antibiotics for known maternal Group B streptococcal colonization.
    Ohlsson A; Shah VS
    Cochrane Database Syst Rev; 2014 Jun; (6):CD007467. PubMed ID: 24915629
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Group B Streptococcus colonization in pregnancy: prevalence and prevention strategies of neonatal sepsis.
    Rausch AV; Gross A; Droz S; Bodmer T; Surbek DV
    J Perinat Med; 2009; 37(2):124-9. PubMed ID: 19021455
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevention of Group B Streptococcal Early-Onset Disease in Newborns: ACOG Committee Opinion Summary, Number 797.
    Obstet Gynecol; 2020 Feb; 135(2):489-492. PubMed ID: 31977793
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Probable early-onset group B streptococcal neonatal sepsis: a serious clinical condition related to intrauterine infection.
    Carbonell-Estrany X; Figueras-Aloy J; Salcedo-Abizanda S; de la Rosa-Fraile M;
    Arch Dis Child Fetal Neonatal Ed; 2008 Mar; 93(2):F85-9. PubMed ID: 17704105
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Group B Streptococci Screening Before Repeat Cesarean Delivery: A Cost-Effectiveness Analysis.
    Albright CM; MacGregor C; Sutton D; Theva M; Hughes BL; Werner EF
    Obstet Gynecol; 2017 Jan; 129(1):111-119. PubMed ID: 27926650
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cost-effectiveness of different treatment strategies with intrapartum antibiotic prophylaxis to prevent early-onset group B streptococcal disease.
    Akker-van Marle ME; Rijnders ME; Dommelen P; Fekkes M; Wouwe JP; Amelink-Verburg MP; Verkerk PH
    BJOG; 2005 Jun; 112(6):820-6. PubMed ID: 15924544
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intrapartum chemoprophylaxis for group B streptococcus infection to prevent neonatal disease: who should be treated?
    Philipson EH; Herson VC
    Am J Perinatol; 1996 Nov; 13(8):487-90. PubMed ID: 8989480
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intrapartum antibiotics for known maternal Group B streptococcal colonization.
    Ohlsson A; Shah VS
    Cochrane Database Syst Rev; 2013 Jan; (1):CD007467. PubMed ID: 23440815
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Group B streptococcus (GBS) and neonatal infections: the case for intrapartum chemoprophylaxis.
    Garland SM; Fliegner JR
    Aust N Z J Obstet Gynaecol; 1991 May; 31(2):119-22. PubMed ID: 1930031
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intrapartum antibiotic prophylaxis increases the incidence of gram-negative neonatal sepsis.
    Levine EM; Ghai V; Barton JJ; Strom CM
    Infect Dis Obstet Gynecol; 1999; 7(4):210-3. PubMed ID: 10449272
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Resource utilization associated with initial hospital stays complicated by early onset group B streptococcal disease.
    Platt R; Adelson-Mitty J; Weissman L; Zaleznik D; Lee ML; Baker CJ
    Pediatr Infect Dis J; 1999 Jun; 18(6):529-33. PubMed ID: 10391183
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Practical management of neonatal sepsis risk in term or near-term infants].
    Astruc D; Zores C; Dillenseger L; Scheib C; Kuhn P
    Arch Pediatr; 2014 Sep; 21(9):1041-8. PubMed ID: 25129319
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk factors for early-onset group B streptococcal sepsis: estimation of odds ratios by critical literature review.
    Benitz WE; Gould JB; Druzin ML
    Pediatrics; 1999 Jun; 103(6):e77. PubMed ID: 10353974
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cost-effectiveness analysis of maternal immunisation against group B Streptococcus (GBS) disease: A modelling study.
    Giorgakoudi K; O'Sullivan C; Heath PT; Ladhani S; Lamagni T; Ramsay M; Al-Janabi H; Trotter C
    Vaccine; 2018 Nov; 36(46):7033-7042. PubMed ID: 30293765
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epidemiology of early-onset neonatal group B streptococcal infection: implications for screening.
    Konrad G; Katz A
    Can Fam Physician; 2007 Jun; 53(6):1055, 2001:e.1-6, 1054. PubMed ID: 17872785
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An analysis of the cost-effectiveness of selected protocols for the prevention of neonatal group B streptococcal infection.
    Yancey MK; Duff P
    Obstet Gynecol; 1994 Mar; 83(3):367-71. PubMed ID: 8127527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.